Elizabeth G. Snyderwine
Chemical Carcinogenesis Section
Laboratory of Experimental Carcinogenesis
National Cancer Institute
Bethesda
USA
Name/email consistency: high
- Mutagenesis and DNA adduct formation in the mouse mammary gland exposed to 2-hydroxyamino-1-methyl-6-phenylimidazo-[4,5-b]pyridine in whole organ culture. Snyderwine, E.G., Yoon, H.S., Knight-Jones, L.P., Tran, M., Schut, H.A., Yu, M. Mutagenesis (2003)
- Mammary gland carcinogenesis by food-derived heterocyclic amines: metabolism and additional factors influencing carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Snyderwine, E.G. Environ. Mol. Mutagen. (2002)
- Highlights of the eighth international conference on carcinogenic/mutagenic N-substituted aryl compounds. Snyderwine, E.G., Sinha, R., Felton, J.S., Ferguson, L.R. Mutat. Res. (2002)
- Mammary gland carcinogenesis by food-derived heterocyclic amines and studies on the mechanisms of carcinogenesis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Snyderwine, E.G., Venugopal, M., Yu, M. Mutat. Res. (2002)
- Effect of CYP1A2 deficiency on heterocyclic amine DNA adduct levels in mice. Snyderwine, E.G., Yu, M., Schut, H.A., Knight-Jones, L., Kimura, S. Food Chem. Toxicol. (2002)
- Mammary gland carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats: possible mechanisms. Snyderwine, E.G. Cancer Lett. (1999)